newsfilter
← Latest News
GlobeNewswire·

AccuStem Sciences, Inc. Announces DTC Eligibility

LONDON and PHOENIX, April 14, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce its uplisting from the OTC Pink Sheets to the OTCQB®�